Post-Trade Analysis: 10x Genomics Inc (TXG) Climbs 2.69, Closing at 20.25

Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

After finishing at $19.72 in the prior trading day, 10x Genomics Inc (NASDAQ: TXG) closed at $20.25, up 2.69%. In other words, the price has increased by $2.69 from its previous closing price. On the day, 1.25 million shares were traded. TXG stock price reached its highest trading level at $20.295 during the session, while it also had its lowest trading level at $19.34.


Our goal is to gain a better understanding of TXG by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.45 and its Current Ratio is at 5.22. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.11.

On May 01, 2024, TD Cowen Downgraded its rating to Hold which previously was Buy and also lowered its target price recommendation from $57 to $32.

On December 14, 2023, Guggenheim started tracking the stock assigning a Buy rating and target price of $60.Guggenheim initiated its Buy rating on December 14, 2023, with a $60 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 22 ’24 when Saxonov Serge sold 4,877 shares for $24.30 per share. The transaction valued at 118,529 led to the insider holds 889,641 shares of the business.

Hindson Benjamin J. sold 4,087 shares of TXG for $99,329 on May 22 ’24. The insider now owns 350,055 shares after completing the transaction at $24.30 per share. On May 22 ’24, another insider, McAnear Justin J., who serves as the Chief Financial Officer of the company, sold 2,936 shares for $24.30 each. As a result, the insider received 71,355 and left with 146,203 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TXG now has a Market Capitalization of 2424087040 and an Enterprise Value of 2144457600. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.88 while its Price-to-Book (P/B) ratio in mrq is 3.37. Its current Enterprise Value per Revenue stands at 3.429 whereas that against EBITDA is -13.065.

Stock Price History:

Over the past 52 weeks, TXG has reached a high of $63.57, while it has fallen to a 52-week low of $19.68. The 50-Day Moving Average of the stock is -24.57%, while the 200-Day Moving Average is calculated to be -49.09%.

Shares Statistics:

The stock has traded on average 1.59M shares per day over the past 3-months and 1170500 shares per day over the last 10 days, according to various share statistics. A total of 105.04M shares are outstanding, with a floating share count of 98.56M. Insiders hold about 17.67% of the company’s shares, while institutions hold 79.60% stake in the company. Shares short for TXG as of 1715731200 were 10132248 with a Short Ratio of 6.26, compared to 1713139200 on 8870437. Therefore, it implies a Short% of Shares Outstanding of 10132248 and a Short% of Float of 11.12.

Most Popular